MiroDry

About Reprise Biomedical

Reprise Biomedical is a private, commercial-stage biotech company founded in 2021 and headquartered in San Diego, with operational offices in Plymouth, MN. The company's core innovation is a proprietary perfusion decellularization process applied to liver tissue, producing collagen-rich, three-dimensional biologic scaffolds (Miro3D, MiroDerm, etc.) for the advanced wound care market. With a product portfolio already on the market and a focus on surgeon needs, Reprise operates in the lucrative biologics segment of the medical device industry, aiming to improve outcomes in complex wound healing.

Therapeutic Areas

Other Wound care Drugs